DarioHealth (DRIO) Tops Q1 EPS by 8c

DarioHealth (NASDAQ: DRIO) reported Q1 EPS of ($0.45), $0.08 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $7.07 million versus the consensus estimate of $6.89 million.

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

You May Also Be Interested In

• Home Depot beats estimates, reaffirms fiscal 2026 guidance
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
• Micron Technology (MU) Reiterated at Buy by UBS as Investor Positioning Skews Cautious